Mitochondrial dysfunction in aging and cancer

68Citations
Citations of this article
82Readers
Mendeley users who have this article in their library.

Abstract

Aging is a major risk factor for developing cancer, suggesting that these two events may represent two sides of the same coin. It is becoming clear that some mechanisms involved in the aging process are shared with tumorigenesis, through convergent or divergent pathways. Increasing evidence supports a role for mitochondrial dysfunction in promoting aging and in supporting tumorigenesis and cancer progression to a metastatic phenotype. Here, a summary of the current knowledge of three aspects of mitochondrial biology that link mitochondria to aging and cancer is presented. In particular, the focus is on mutations and changes in content of the mitochondrial genome, activation of mitochondria-to-nucleus signaling and the newly discovered mitochondria-telomere communication.

Cite

CITATION STYLE

APA

Moro, L. (2019, November 1). Mitochondrial dysfunction in aging and cancer. Journal of Clinical Medicine. MDPI. https://doi.org/10.3390/jcm8111983

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free